Skip to main content
"My lung cancer has met its match with me" — METex14, Meet Kathy
Support throughout treatment

There's a lot of information to take in when starting treatment. You may have questions. Here are some important resource details about TABRECTA, including insurance coverage and financial resources.

How much does TABRECTA cost?

The cost of TABRECTA depends on a few factors. Visit the Novartis Oncology Patient Support website to get a better idea of what your cost may be. You may qualify for a TABRECTA co-pay card.

Our Patient Assistance Now Oncology (PANO) program was created to assist you with accessing your Novartis medicine(s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.

To learn more, call 1-800-282-7630 or visit

 You may be eligible for immediate co-pay savings on your TABRECTA prescription.

  • Eligible patients with private insurance may pay $0 per month

  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*

Novartis Universal Co-Pay Card

To find out if you are eligible for the Novartis Oncology Universal Co-pay Program, 
call 1-877-577-7756 or visit

See if you're eligible

*Limitations apply. This offer is only available to patients with private insurance. The program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, visit or call 1-877-577-7756.

With the TABRECTA 14-Day Free Trial Program, you can receive a free supply of TABRECTA for a US Food and Drug Administration (FDA)–approved indication. The supply can be shipped directly to your home or another convenient location so you can start treatment immediately. Program rules may vary.

Important Safety Information

TABRECTA may cause serious side effects. Tell your health care provider right away if you get any of the following:

  • Lung or breathing problems. TABRECTA may cause inflammation of the lungs that can cause death. Tell your health care provider right away if...

Approved Use

TABRECTA is a prescription medicine used to treat adults with a kind of lung cancer called non-small cell lung cancer (NSCLC) that:

  • has spread to other parts of the body (metastatic), and 
  • whose tumors have an abnormal mesenchymal ...